Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

Cell

Volumn 166, Issue 3, 2016, Pages 609-623

  Joyce, M Gordon ^a   Wheatley, Adam K ^a   Thomas, Paul V ^a   Chuang, Gwo Yu ^a   Soto, Cinque ^a   Bailer, Robert T ^a   Druz, Aliaksandr ^a   Georgiev, Ivelin S ^a,b,c   Gillespie, Rebecca A ^a   Kanekiyo, Masaru ^a   Kong, Wing Pui ^a   Leung, Kwanyee ^a   Narpala, Sandeep N ^a   Prabhakaran, Madhu S ^a   Yang, Eun Sung ^a   Zhang, Baoshan ^a   Zhang, Yi ^a   Asokan, Mangaiarkarasi ^a   Boyington, Jeffrey C ^a   Bylund, Tatsiana ^a   Darko, Sam ^a   Lees, Christopher R ^a   Ransier, Amy ^a   Shen, Chen Hsiang ^a   Wang, Lingshu ^a   Whittle, James R ^a   Wu, Xueling ^a   Yassine, Hadi M ^a   Santos, Celia ^a   Matsuoka, Yumiko ^a   Tsybovsky, Yaroslav ^d   Baxa, Ulrich ^d   Mullikin, James C ^e   Subbarao, Kanta ^a   Douek, Daniel C ^a   Graham, Barney S ^a   Koup, Richard A ^a   Ledgerwood, Julie E ^a   Roederer, Mario ^a   Shapiro, Lawrence ^a,f   Kwong, Peter D ^a   Mascola, John R ^a   McDermott, Adrian B ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ARTICLE; B LYMPHOCYTE; CROSS REACTION; CRYSTAL STRUCTURE; GENE SEQUENCE; GROUP 1 INFLUENZA A VIRUS; GROUP 2 INFLUENZA A VIRUS; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H5N1); MEMORY CELL; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VACCINATION; VIRUS NEUTRALIZATION; VIRUS STRAIN; ADULT; CHEMISTRY; CLINICAL TRIAL; FEMALE; GENE REARRANGEMENT; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; MIDDLE AGED; MOLECULAR MODEL; PHASE 1 CLINICAL TRIAL; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; YOUNG ADULT;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; YOUNG ADULT;

EID: 84979581546     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.06.043     Document Type: Article

References (40)

1. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T., McVean, G.A., 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
2. Adderson, E.E., Shackelford, P.G., Quinn, A., Wilson, P.M., Cunningham, M.W., Insel, R.A., Carroll, W.L., Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. Nucleotide sequences of monospecific anti-Haemophilus antibodies and polyspecific antibodies cross-reacting with self antigens. J. Clin. Invest. 91 (1993), 2734–2743.
3. Boyd, S.D., Marshall, E.L., Merker, J.D., Maniar, J.M., Zhang, L.N., Sahaf, B., Jones, C.D., Simen, B.B., Hanczaruk, B., Nguyen, K.D., et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med., 1, 2009, 12ra23.
4. Butt, K.M., Smith, G.J., Chen, H., Zhang, L.J., Leung, Y.H., Xu, K.M., Lim, W., Webster, R.G., Yuen, K.Y., Peiris, J.S., Guan, Y., Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. 43 (2005), 5760–5767.
5. Corti, D., Voss, J., Gamblin, S.J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S.G., Pinna, D., Minola, A., Vanzetta, F., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333 (2011), 850–856.
6. DeKosky, B.J., Kojima, T., Rodin, A., Charab, W., Ippolito, G.C., Ellington, A.D., Georgiou, G., In-depth determination and analysis of the human paired heavy- and light-chain antibody repertoire. Nat. Med. 21 (2015), 86–91.
7. Dosenovic, P., von Boehmer, L., Escolano, A., Jardine, J., Freund, N.T., Gitlin, A.D., McGuire, A.T., Kulp, D.W., Oliveira, T., Scharf, L., et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice. Cell 161 (2015), 1505–1515.
8. Dreyfus, C., Laursen, N.S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D.C., Lee, J.H., Metlagel, Z., Bujny, M.V., Jongeneelen, M., et al. Highly conserved protective epitopes on influenza B viruses. Science 337 (2012), 1343–1348.
9. Ekiert, D.C., Bhabha, G., Elsliger, M.A., Friesen, R.H., Jongeneelen, M., Throsby, M., Goudsmit, J., Wilson, I.A., Antibody recognition of a highly conserved influenza virus epitope. Science 324 (2009), 246–251.
10. Ekiert, D.C., Friesen, R.H., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H.J., Brandenburg, B., et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333 (2011), 843–850.
11. Georgiev, I.S., Doria-Rose, N.A., Zhou, T., Kwon, Y.D., Staupe, R.P., Moquin, S., Chuang, G.Y., Louder, M.K., Schmidt, S.D., Altae-Tran, H.R., et al. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization. Science 340 (2013), 751–756.
12. Gorman, J., Soto, C., Yang, M.M., Davenport, T.M., Guttman, M., Bailer, R.T., Chambers, M., Chuang, G.Y., DeKosky, B.J., Doria-Rose, N.A., et al., NISC Comparative Sequencing Program. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design. Nat. Struct. Mol. Biol. 23 (2016), 81–90.
13. Henry Dunand, C.J., Wilson, P.C., Restricted, canonical, stereotyped and convergent immunoglobulin responses. Philos. Trans. R. Soc. Lond. B Biol. Sci., 370, 2015, 10.1098/rstb.2014.0238.
14. Huang, C.C., Venturi, M., Majeed, S., Moore, M.J., Phogat, S., Zhang, M.Y., Dimitrov, D.S., Hendrickson, W.A., Robinson, J., Sodroski, J., et al. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. USA 101 (2004), 2706–2711.
15. Impagliazzo, A., Milder, F., Kuipers, H., Wagner, M.V., Zhu, X., Hoffman, R.M., van Meersbergen, R., Huizingh, J., Wanningen, P., Verspuij, J., et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349 (2015), 1301–1306.
16. Jardine, J.G., Ota, T., Sok, D., Pauthner, M., Kulp, D.W., Kalyuzhniy, O., Skog, P.D., Thinnes, T.C., Bhullar, D., Briney, B., et al. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349 (2015), 156–161.
17. Jiang, N., He, J., Weinstein, J.A., Penland, L., Sasaki, S., He, X.S., Dekker, C.L., Zheng, N.Y., Huang, M., Sullivan, M., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci. Transl. Med., 5, 2013, 171ra19.
18. Kabat, E.A., Wu, T.T., Perry, H., Gottesman, K., Foeller, C., Sequences of Proteins of Immunological Interest, Fifth Edition. 1991, NIH Publication No. 91-3242.
19. Kallewaard, N.L., Corti, D., Collins, P.J., Neu, J., McAuliffe, J.M., Benjamin, E., Wachter-Rosati, L., Palmer-Hill, F.J., Yuan, A.Q., Walker, P.A., et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166 (2016), 596–608 this issue.
20. Kashyap, A.K., Steel, J., Rubrum, A., Estelles, A., Briante, R., Ilyushina, N.A., Xu, L., Swale, R.E., Faynboym, A.M., Foreman, P.K., et al. Protection from the 2009 H1N1 pandemic influenza by an antibody from combinatorial survivor-based libraries. PLoS pathogens, 6, 2010, e1000990.
21. Khurana, S., Wu, J., Dimitrova, M., King, L.R., Manischewitz, J., Graham, B.S., Ledgerwood, J.E., Golding, H., DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. J. Infect. Dis. 208 (2013), 413–417.
22. Krammer, F., Palese, P., Steel, J., Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin. Curr. Top. Microbiol. Immunol. 386 (2015), 301–321.
23. Kwong, P.D., Mascola, J.R., Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37 (2012), 412–425.
24. Ledgerwood, J.E., Wei, C.J., Hu, Z., Gordon, I.J., Enama, M.E., Hendel, C.S., McTamney, P.M., Pearce, M.B., Yassine, H.M., Boyington, J.C., et al., VRC 306 Study Team. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect. Dis. 11 (2011), 916–924.
25. Ledgerwood, J.E., Zephir, K., Hu, Z., Wei, C.J., Chang, L., Enama, M.E., Hendel, C.S., Sitar, S., Bailer, R.T., Koup, R.A., et al., VRC 310 Study Team. Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. J. Infect. Dis. 208 (2013), 418–422.
26. Li, G.M., Chiu, C., Wrammert, J., McCausland, M., Andrews, S.F., Zheng, N.Y., Lee, J.H., Huang, M., Qu, X., Edupuganti, S., et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA 109 (2012), 9047–9052.
27. Lingwood, D., McTamney, P.M., Yassine, H.M., Whittle, J.R., Guo, X., Boyington, J.C., Wei, C.J., Nabel, G.J., Structural and genetic basis for development of broadly neutralizing influenza antibodies. Nature 489 (2012), 566–570.
28. Morens, D.M., Taubenberger, J.K., Fauci, A.S., H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity. MBio, 4, 2013, 10.1128/mBio.00445-13.
29. Nakamura, G., Chai, N., Park, S., Chiang, N., Lin, Z., Chiu, H., Fong, R., Yan, D., Kim, J., Zhang, J., et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 14 (2013), 93–103.
30. Pappas, L., Foglierini, M., Piccoli, L., Kallewaard, N.L., Turrini, F., Silacci, C., Fernandez-Rodriguez, B., Agatic, G., Giacchetto-Sasselli, I., Pellicciotta, G., et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516 (2014), 418–422.
31. Schmidt, A.G., Therkelsen, M.D., Stewart, S., Kepler, T.B., Liao, H.X., Moody, M.A., Haynes, B.F., Harrison, S.C., Viral receptor-binding site antibodies with diverse germline origins. Cell 161 (2015), 1026–1034.
32. Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M., Swayne, D., Bender, C., Huang, J., et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 (1998), 393–396.
33. Sui, J., Hwang, W.C., Perez, S., Wei, G., Aird, D., Chen, L.M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16 (2009), 265–273.
34. Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L.L., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PloS one, 3, 2008, e3942.
35. Wheatley, A.K., Whittle, J.R., Lingwood, D., Kanekiyo, M., Yassine, H.M., Ma, S.S., Narpala, S.R., Prabhakaran, M.S., Matus-Nicodemos, R.A., Bailer, R.T., et al. H5N1 vaccine-elicited memory B Cells are genetically constrained by the IGHV locus in the recognition of a neutralizing epitope in the hemagglutinin stem. J. Immunol. 195 (2015), 602–610.
36. Whittle, J.R., Zhang, R., Khurana, S., King, L.R., Manischewitz, J., Golding, H., Dormitzer, P.R., Haynes, B.F., Walter, E.B., Moody, M.A., et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108 (2011), 14216–14221.
37. Whittle, J.R., Wheatley, A.K., Wu, L., Lingwood, D., Kanekiyo, M., Ma, S.S., Narpala, S.R., Yassine, H.M., Frank, G.M., Yewdell, J.W., et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88 (2014), 4047–4057.
38. Wu, Y., Cho, M., Shore, D., Song, M., Choi, J., Jiang, T., Deng, Y.Q., Bourgeois, M., Almli, L., Yang, H., et al. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat. Commun., 6, 2015, 7708.
39. Yassine, H.M., Boyington, J.C., McTamney, P.M., Wei, C.J., Kanekiyo, M., Kong, W.P., Gallagher, J.R., Wang, L., Zhang, Y., Joyce, M.G., et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 21 (2015), 1065–1070.
40. Zhou, T., Zhu, J., Wu, X., Moquin, S., Zhang, B., Acharya, P., Georgiev, I.S., Altae-Tran, H.R., Chuang, G.Y., Joyce, M.G., et al., NISC Comparative Sequencing Program. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity 39 (2013), 245–258.